|
|
|
|
|
|
|
|
Miscellaneous Origins
The information contained in these documents is a statement of consensus of BC Cancer Agency professionals regarding their views of currently accepted approaches to treatment. Any clinician seeking to apply or consult these documents is expected to use independent medical judgement in the context of individual clinical circumstances to determine any patient's care or treatment. Use of these documents is at your own risk and is subject to BC Cancer Agency's terms of use available at www.bccancer.bc.ca/legal.htm .
PLEASE NOTE: All links in the table below open PDF documents
| PROTOCOL CODE and DESCRIPTION |
AVAILABLE DOCUMENTS
(revision date indicated in red) |
| MOIT: Therapy for Solid Tumours using Intrathecal Methotrexate and/or Thiotepa and/or Cytarabine. |
- Protocol (01 May 2009)
- Preprinted order (01 May 2009) |
| UMOHDMTX: Meningeal Disease (Miscellaneous Tumour Origins) using High Dose Methotrexate with Leucovorin Rescue. |
- Protocol (01 May 2009) |
|
|
|